Product Code: PM1248
The global alopecia market size is expected to reach USD 5.83 billion by 2030, according to a new study by Polaris Market Research. The report "Alopecia Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Pharmaceutical, Devices); By Disease Type (Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia); By Gender: By End-Use; By Region; Segment Forecast 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global market is anticipated to develop as the incidence of chronic diseases, including cancer, polycystic ovary syndrome (PCOS), and arthritis, rises, coupled with stress levels, the aging population, hormonal imbalances, and bad diets. In addition, rising air and water pollution, which impairs the health of the hair and causes baldness and early breakage, and an increase in cancer treatments that result in hair loss from patients' bodies, are likely to further fuel the industry's expansion over the forecast period.
The rising number of clinical studies for its therapy is predicted to help in the worldwide industry's expansion during the forecast period. For instance, in order to assess the effectiveness and safety of such injections of 0.5 % minoxidil to treat female androgenetic hair loss, researchers from the University of Brazil carried out a randomized, placebo-controlled experiment. The results showed that minoxidil intradermal injections had a positive safety profile and were more successful than a placebo in treating female androgenetic hair loss.
Moreover, the market has a strong pipeline of products and the rising acceptance of laser-based therapy to treat hair loss disorders. One of the main factors driving this industry is technological progress in hair loss therapy. It is anticipated that the advent of low-level laser therapy also the introduction of accessory products would accelerate industry expansion.
Alopecia Market Report Highlights
Areata segment is anticipated to register a significant growth rate over the study period, due to advancements in innovative therapies and supportive measures in the approval process, the industry is predicted to grow significantly during the projected period
Pharmaceutical segment accounted for a significant share in the market which is accelerated by the low cost of pharmaceutical items and increased consumption of prescription and over-the-counter medications
Male segment is expected to hold the significant revenue share over the forecast period due to the elements including men's increased cigarette consumption and a growing elderly population throughout the projected period
North America is expected to grow at a lucrative CAGR rate over the projected period on account of the increasing high disease prevalence, increased consumer awareness, pro-active government action, technological advancements, and improvements to the healthcare system's infrastructure
The global market includes Aclaris Therapeutics, Fagron, Follicum, Cipla, Arcutis Biotherapeutics, Dr. Reddy's Labs, Himalaya Wellness, Eli Lilly and Company, GlaxoSmithKline; Aurobindo Pharma; Mylan, Concert Pharmaceutical, and Teva Pharmaceutical.
Polaris Market Research has segmented the Alopecia Market report based on disease type, treatment type, gender, end-use, and region:
Alopecia, Disease Type Outlook (Revenue - USD Billion, 2018 - 2030)
Alopecia Areata
Cicatricial
Traction
Androgenetic
Alopecia, Treatment Type Outlook (Revenue - USD Billion, 2018 - 2030)
Pharmaceutical
Devices
Alopecia, Gender Outlook (Revenue - USD Billion, 2018 - 2030)
Male
Female
Alopecia, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)
Homecare Settings
Dermatology Clinics
Alopecia, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Alopecia Market Insights
- 4.1. Alopecia - Industry Snapshot
- 4.2. Alopecia Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing global prevalence of alopecia
- 4.2.1.2. Increasing global healthcare expenditure
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Lack of reimbursement policies for alopecia treatment
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Alopecia Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Alopecia Market, by Disease Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 5.3. Alopecia Areata
- 5.3.1. Global Alopecia Market, by Alopecia Areata, by Region, 2018 - 2030 (USD Billion)
- 5.4. Cicatricial
- 5.4.1. Global Alopecia Market, by Cicatricial, by Region, 2018 - 2030 (USD Billion)
- 5.5. Traction
- 5.5.1. Global Alopecia Market, by Traction, by Region, 2018 - 2030 (USD Billion)
- 5.6. Androgenetic Alopecia
- 5.6.1. Global Alopecia Market, by Androgenetic Alopecia, by Region, 2018 - 2030 (USD Billion)
6. Global Alopecia Market, by Treatment Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 6.3. Pharmaceutical
- 6.3.1. Global Alopecia Market, by Pharmaceutical, by Region, 2018 - 2030 (USD Billion)
- 6.4. Devices
- 6.4.1. Global Alopecia Market, by Devices, by Region, 2018 - 2030 (USD Billion)
7. Global Alopecia Market, by Gender
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 7.3. Male
- 7.3.1. Global Alopecia Market, by Male, by Region, 2018 - 2030 (USD Billion)
- 7.4. Female
- 7.4.1. Global Alopecia Market, by Female, by Region, 2018 - 2030 (USD Billion)
8. Global Alopecia Market, by End-user
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 8.3. Homecare Settings
- 8.3.1. Global Alopecia Market, by Homecare Settings, by Region, 2018 - 2030 (USD Billion)
- 8.4. Dermatology Clinics
- 8.4.1. Global Alopecia Market, by Dermatology Clinics, by Region, 2018 - 2030 (USD Billion)
9. Global Alopecia Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Alopecia Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 9.3. Alopecia Market - North America
- 9.3.1. North America: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.3.2. North America: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.3.3. North America: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.3.4. North America: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.3.5. Alopecia Market - U.S.
- 9.3.5.1. U.S.: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.3.5.2. U.S.: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.3.5.3. U.S.: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.3.5.4. U.S.: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.3.6. Alopecia Market - Canada
- 9.3.6.1. Canada: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.3.6.2. Canada: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.3.6.3. Canada: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.3.6.4. Canada: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.4. Alopecia Market - Europe
- 9.4.1. Europe: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.2. Europe: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.4.3. Europe: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.4.4. Europe: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.4.5. Alopecia Market - UK
- 9.4.5.1. UK: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.5.2. UK: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.4.5.3. UK: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.4.5.4. UK: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.4.6. Alopecia Market - France
- 9.4.6.1. France: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.6.2. France: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.4.6.3. France: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.4.6.4. France: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.4.7. Alopecia Market - Germany
- 9.4.7.1. Germany: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.7.2. Germany: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.4.7.3. Germany: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.4.7.4. Germany: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.4.8. Alopecia Market - Italy
- 9.4.8.1. Italy: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.8.2. Italy: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.4.8.3. Italy: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.4.8.4. Italy: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.4.9. Alopecia Market - Spain
- 9.4.9.1. Spain: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.9.2. Spain: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.4.9.3. Spain: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.4.9.4. Spain: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.4.10. Alopecia Market - Netherlands
- 9.4.10.1. Netherlands: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.10.2. Netherlands: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.4.10.3. Netherlands: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.4.10.4. Netherlands: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.4.11. Alopecia Market - Russia
- 9.4.11.1. Russia: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.11.2. Russia.: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.4.11.3. Russia: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.4.11.4. Russia: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.5. Alopecia Market - Asia Pacific
- 9.5.1. Asia Pacific: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.2. Asia Pacific: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.5.3. Asia Pacific: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.5.4. Asia Pacific: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.5.5. Alopecia Market - China
- 9.5.5.1. China: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.5.2. China.: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.5.5.3. China: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.5.5.4. China: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.5.6. Alopecia Market - India
- 9.5.6.1. India: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.6.2. India.: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.5.6.3. India: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.5.6.4. India: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.5.7. Alopecia Market - Japan
- 9.5.7.1. Japan: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.7.2. Japan.: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.5.7.3. Japan: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.5.7.4. Japan: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.5.8. Alopecia Market - Malaysia
- 9.5.8.1. Malaysia: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.8.2. Malaysia.: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.5.8.3. Malaysia: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.5.8.4. Malaysia: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.5.9. Alopecia Market - Indonesia
- 9.5.9.1. Indonesia: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.9.2. Indonesia.: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.5.9.3. Indonesia: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.5.9.4. Indonesia: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.5.10. Alopecia Market - South Korea
- 9.5.10.1. South Korea: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.10.2. South Korea.: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.5.10.3. South Korea: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.5.10.4. South Korea: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.6. Alopecia Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.6.2. Middle East & Africa: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.6.3. Middle East & Africa: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.6.4. Middle East & Africa: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.6.5. Alopecia Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.6.5.2. Saudi Arabia: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.6.5.3. Saudi Arabia: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.6.5.4. Saudi Arabia: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.6.6. Alopecia Market - South Africa
- 9.6.6.1. South Africa: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.6.6.2. South Africa: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.6.6.3. South Africa: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.6.6.4. South Africa: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.6.7. Alopecia Market - Israel
- 9.6.7.1. Israel: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.6.7.2. Israel: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.6.7.3. Israel: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.6.7.4. Israel: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.6.8. Alopecia Market - UAE
- 9.6.8.1. UAE: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.6.8.2. UAE: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.6.8.3. UAE: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.6.8.4. UAE: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.7. Alopecia Market - Latin America
- 9.7.1. Latin America: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.7.2. Latin America: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.7.3. Latin America: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.7.4. Latin America: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.7.5. Alopecia Market - Mexico
- 9.7.5.1. Mexico: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.7.5.2. Mexico: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.7.5.3. Mexico: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.7.5.4. Mexico: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.7.6. Alopecia Market - Brazil
- 9.7.6.1. Brazil: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.7.6.2. Brazil: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.7.6.3. Brazil: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.7.6.4. Brazil: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
- 9.7.7. Alopecia Market - Argentina
- 9.7.7.1. Argentina: Alopecia Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.7.7.2. Argentina: Alopecia Market, by End-user, 2018 - 2030 (USD Billion)
- 9.7.7.3. Argentina: Alopecia Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.7.7.4. Argentina: Alopecia Market, by Gender, 2018 - 2030 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Aclaris Therapeutics
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Fagron
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Follicum
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Cipla Inc
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Arcutis Biotherapeutics
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Dr. Reddy's Laboratories
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Himalaya Wellness
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Eli Lilly and Company
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. GlaxoSmithKline
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Aurobindo Pharma
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Mylan
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Concert Pharmaceuticals
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Teva Pharmaceutical
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development